Regenerative medicine is the exciting and ever dynamic branch of medicine with the purpose of replacing, repairing, renewing or engineering human cells, tissues, organs or their building blocks, utilizing the body’s innate cellular pathways for the purposes of restoring function and homeostasis in the body. Regenerative cellular biomedical therapies are potent adjuncts to the natural healing mechanisms of the human body to reduce, relieve, or manage painful and certain chronic conditions and improve function.

The goal of both Regenerative and Anti-Aging Medicine is to optimize both longevity and to enhance the quality of life. It is based on the premise that aging, in the traditional sense, and tissue degeneration and accompanying pain and inflammation, is a condition or state of “disease” rather than a natural progression of human longevity potential.


Perinatal tissue is primarily used as Allograft sourcing. Umbilical Cord tissue and Amniotic cells have Growth Factors and Cytokines and a viable concentration of cells but can be easily attained and used for Regenerative Medicine with more ease than bone marrow and adipose aspirate without the increased cost, time, inconvenience, and pain to the patient.

Flowable Amniotic Tissue & Amniotic Fluid:

Flowable Amnion tissue and Amniotic fluid are obtained from Placental products from healthy live birthed babies. Amniotic tissue flowables promote regeneration with viable cellular material and have anti-inflammatory properties (Active Biologics such as Cytokines & Growth Factors, Secretomes, Exosomes, and microRNA). Amniotic fluid alone has similar properties with fewer viable cells. These cytokines and growth factors may impact collagen and other tissue production.

Umbilical Cord Blood (with HSCs)

Umbilical Cord Blood Stem Cells are derived from the umbilical cord and the placenta and are donated by mothers of normal healthy live birthed babies. This cord blood contains mostly HSCs with some MSCs. The current FDA guidelines mandate that Cord Blood is only to be used on first and second degree relatives of derived cord blood.

Flowable Umbilical Cord Tissue (with MSCs derived from Wharton’s Jelly)

Flowable Umbilical Cord Tissue is considered by thought leaders in biomedical research to hold the promise of innovation in regenerative medicine. These sources contain extracellular matrix (structural healing) components, Stem Cells (MSCs) and growth factors for the efficient regeneration of injured or degenerated tissue through the replacement of cells which are identical to the original tissue. The cells in the Wharton’s Jelly of the cord genetically code for Adult Stem Cell (MSC) production. The extracellular components contained accelerate Collagen production.  Due to Wharton’s Jelly, the MSCs rate of growth, immune-privileged status, non-tumor-making property, and lack of ethical concerns, cord tissue is an ideal MSC source.